In colitis-associated colorectal cancer, GSDME-mediated pyroptosis promotes tumorigenesis through the release of HMGB1, which subsequently activates the ERK1/2 pathway to drive tumor cell proliferation [186]. The gene discussed is MAPK3; the disease is neoplasm.